It is also known that IL-6 binds to its receptors forms a complex that activates the STAT3; thus, the STAT3 is phosphorylated via the JAK, and this activation is preferred by the PKM2, which leads to the promotion of serine hydroxymethyltransferase 2 transcription in cancer [44,45]. This evidence concerns the gene IL6 and cancer.